Differences In D-Dimer Levels Of Moderate And Severe Covid-19 Patients Treated At Hajj Adam Malik Hospital, Medan
DOI:
https://doi.org/10.51601/ijhp.v5i1.396Abstract
An outbreak of coronavirus disease 2019 (COVID-19), initially reported in December 2019 in Wuhan, Hubei Province, China, emerged as a mysterious pneumonia caused by the novel β-coronavirus, 2019-nCoV. Among hospitalized COVID-19 patients, elevated D-dimer levels and impaired hemostasis have been commonly observed, often associated with disease severity and mortality. This study aimed to assess differences in D-dimer levels among mild, moderate, and severe COVID-19 patients in a cross-sectional design involving 36 confirmed COVID-19 patients hospitalized at H. Adam Malik General Hospital Medan. Conducted from August to October 2021 at the Departments of Clinical Pathology and Pulmonology and Respiratory Medicine, the study used consecutive sampling. The participants had an average age of 50.92 years, with hypertension and diabetes mellitus being the most common comorbidities. The average D-dimer level was 1324.28 ng/mL (SD = 2360.45 ng/mL), ranging from 100 ng/mL to 13,420 ng/mL. A significant difference in D-dimer levels was observed between patients with moderate and severe COVID-19, highlighting its potential role in evaluating disease progression and severity.
References
Y.-R. Guo et al., “The Origin, Transmission and Clinical Therapies On Coronavirus Disease 2019 (COVID-19) Outbreak – An Update On The Status,” Mil. Med. Res., vol. 7, no. 1, p. 11, Dec. 2020, doi: 10.1186/s40779-020-00240-0.
World Health Organization, “WHO Director-General’s Opening Remarks at The Media Briefing on COVID-19 - 11 March 2020,” WHO, 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed Jan. 06, 2025).
W. Cao and T. Li, “COVID-19: Towards Understanding of Pathogenesis,” Cell Res., vol. 30, no. 5, pp. 367–369, May 2020, doi: 10.1038/s41422-020-0327-4.
F. Di Gennaro et al., “Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review,” Int. J. Environ. Res. Public Health, vol. 17, no. 8, p. 2690, Apr. 2020, doi: 10.3390/ijerph17082690.
S. Zaim, J. H. Chong, V. Sankaranarayanan, and A. Harky, “COVID-19 and Multiorgan Response,” Curr. Probl. Cardiol., vol. 45, no. 8, p. 100618, Aug. 2020, doi: 10.1016/j.cpcardiol.2020.100618.
S. H. Nile, A. Nile, J. Qiu, L. Li, X. Jia, and G. Kai, “COVID-19: Pathogenesis, Cytokine Storm and Therapeutic Potential of Interferons,” Cytokine Growth Factor Rev., vol. 53, pp. 66–70, Jun. 2020, doi: 10.1016/j.cytogfr.2020.05.002.
Y. Yao et al., “D-Dimer as A Biomarker For Disease Severity and Mortality In COVID-19 Patients: A Case Control Study,” J. Intensive Care, vol. 8, no. 1, p. 49, Dec. 2020, doi: 10.1186/s40560-020-00466-z.
T. Zhang, Q. Wu, and Z. Zhang, “Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak,” Curr. Biol., vol. 30, no. 7, pp. 1346-1351.e2, Apr. 2020, doi: 10.1016/j.cub.2020.03.022.
M. Marietta et al., “COVID-19 and Haemostasis: A Position Paper From Italian Society On Thrombosis and Haemostasis (SISET),” Blood Transfus., vol. 18, no. 3, pp. 167–169, May 2020, doi: 10.2450/2020.0083-20.
M. Panigada et al., “Hypercoagulability of COVID‐19 Patients in Intensive Care Unit: A Report of Thromboelastography Findings and Other Parameters of Hemostasis,” J. Thromb. Haemost., vol. 18, no. 7, pp. 1738–1742, Jul. 2020, doi: 10.1111/jth.14850.
Y. Ryadi, S. S. Rahardjo, and B. Ichsan, “Meta-Analysis: The Effect of D-Dimer on Mortality in Patients with COVID-19,” J. Epidemiol. Public Heal., vol. 7, no. 4, pp. 552–561, Oct. 2022, doi: 10.26911/jepublichealth.2022.07.04.11.
Notoatmodjo, Metode Penelitian Kesehatan. Jakarta: Rineka Cipta, 2012.
I. K. Swarjana, Metode Penelitian Kesehatan. Surabaya: Andi Offset, 2016.
Y. Agnesia, S. W. Sari, H. Nu’man, D. W. Ramadhani, and Nopianto, Buku Ajar Metode Penelitian Kesehatan. Pekalongan: Penerbit NEM, 2023.
I. A. Liberty, Metode Penelitian Kesehatan. Pekalongan: Penerbit NEM, 2024.
V. W. Sujarweni, SPSS untuk Penelitian. Yogyakarta: Pustaka Baru Press, 2015.
P. ldy Rochmat, Analisis Statistik Ekonomi dan Bisnis dengan SPSS. Yogyakarta: Fadilatama, 2016.
D. Tascioglu, K. Yalta, and E. Yetkin, “Hypertension and Diabetes Mellitus in Patients with COVID 19: A Viewpoint on Mortality,” Cardiovasc. Endocrinol. Metab., vol. 9, no. 3, pp. 108–109, Jun. 2020, doi: 10.1097/XCE.0000000000000213.
Z. Zheng et al., “Risk Factors of Critical & Mortal COVID-19 Cases: A Systematic Literature Review and Meta-Analysis,” J. Infect., vol. 81, no. 2, pp. 16–25, Aug. 2020, doi: 10.1016/j.jinf.2020.04.021.
W. Guan et al., “Comorbidity and its Impact on 1590 Patients with COVID-19 in China: A Nationwide Analysis,” Eur. Respir. J., vol. 55, no. 5, p. 2000547, May 2020, doi: 10.1183/13993003.00547-2020.
M. Levi, J. Thachil, T. Iba, and J. H. Levy, “Coagulation Abnormalities and Thrombosis in Patients with COVID-19,” Lancet Haematol., vol. 7, no. 6, pp. e438–e440, Jun. 2020, doi: 10.1016/S2352-3026(20)30145-9.
B. M. Henry, J. Vikse, S. Benoit, E. J. Favaloro, and G. Lippi, “Hyperinflammation and Derangement of Renin-Angiotensin-Aldosterone System in COVID-19: A Novel Hypothesis For Clinically Suspected Hypercoagulopathy and Microvascular Immunothrombosis,” Clin. Chim. Acta, vol. 507, pp. 167–173, Aug. 2020, doi: 10.1016/j.cca.2020.04.027.
Y. Oussou, Z. Nadhil, and M. Cherti, “Acute Stroke in Young Patient: Also Think About Coronavirus ! (About a Case and a Review of the Literature),” Int. J. Adv. Res., vol. 9, no. 01, pp. 110–115, 2021, doi: 10.21474/ijar01/12282.
D. Wichmann et al., “Autopsy Findings and Venous Thromboembolism in Patients With COVID-19,” Ann. Intern. Med., vol. 173, no. 4, pp. 268–277, Aug. 2020, doi: 10.7326/M20-2003.
A. Kollias, K. G. Kyriakoulis, E. Dimakakos, G. Poulakou, G. S. Stergiou, and K. Syrigos, “Thromboembolic Risk and Anticoagulant Therapy in COVID‐19 Patients: Emerging Evidence and Call For Action,” Br. J. Haematol., vol. 189, no. 5, pp. 846–847, Jun. 2020, doi: 10.1111/bjh.16727.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Denny Hadi, Jelita Siregar, Noni Novisari Soeroso
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
